[Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases]. [electronic resource]
- Minerva cardioangiologica Oct 1998
- 9-15 p. digital
Publication Type: English Abstract; Journal Article
0026-4725
Alprostadil--pharmacology Arteriosclerosis--drug therapy Cost-Benefit Analysis Costs and Cost Analysis Cyclodextrins--pharmacology Diabetic Angiopathies--drug therapy Fibrinolytic Agents--therapeutic use Gangrene--drug therapy Humans Intermittent Claudication Ischemia--drug therapy Leg--blood supply Peripheral Vascular Diseases--drug therapy Quality of Life